#Compounding
FDA 503A and 503B compounding, EU compounding rules, what they allow and prohibit.
Photos vs Self-Report: GLP-1 Accuracy
A University of Michigan study compared medication photos against self-reports for 322 GLP-1 users and found real gaps in compounded-drug reporting.
5mg vs 10mg Vials: What's Actually Missing
CJC-1295 and ipamorelin vial size doesn't decide potency. What's actually missing is any FDA-recognized reconstitution or stability standard for either peptide.
The Real Risks of Grey-Market Peptides
Unapproved injectable peptides like TB-500, sold online with no prescription, carry contamination, dosing, and safety risks the FDA is still reviewing.
Is a 'research use only' peptide legal?
A research use only label on a peptide vial does not answer whether a clinic can legally give it to a patient.
Old retatrutide pen: still safe to use?
Retatrutide is investigational, and even FDA-approved GLP-1 pens must be discarded weeks after first use, not months later.
Compounded tirzepatide with B6 explained
Compounded tirzepatide, including preparations with added vitamin B6, is not the licensed medicine. Here is what is documented and what is not.